Form 8-K - Current report:
SEC Accession No. 0001140361-19-022481
Filing Date
2019-12-13
Accepted
2019-12-13 07:00:53
Documents
12
Period of Report
2019-12-11
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm   iXBRL 8-K 43003
  Complete submission text file 0001140361-19-022481.txt   185893

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ions-20191211.xsd EX-101.SCH 4198
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20191211_lab.xml EX-101.LAB 23692
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20191211_pre.xml EX-101.PRE 16832
5 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 4062
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 191283396
SIC: 2834 Pharmaceutical Preparations